Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1990 Jul;10:18–20.

Resection guided by antibodies (REGAJ): a diagnostic procedure during second-look operation in ovarian cancer patients.

W Jäger 1, H Feistel 1, E M Paterok 1, G Ronay 1, A H Tulusan 1, F Wolf 1, N Lang 1
PMCID: PMC2149505  PMID: 2383476

Abstract

A hand-held probe has been used to localise the 131I-labelled antibody OC125 during second-look operation (SLO) in 22 ovarian cancer patients. In six patients microscopic cancer was detected with the procedure and a further six patients with areas of increased radioactivity during SLO developed recurrent disease within 1-4 months. We suggest examining resection guided by antibodies as a possible means of removing antigen-producing cancerous tissues during surgery.

Full text

PDF
18

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chatal J. F., Fumoleau P., Saccavini J. C., Thedrez P., Curtet C., Bianco-Arco A., Chetanneau A., Peltier P., Kremer M., Guillard Y. Immunoscintigraphy of recurrences of gynecologic carcinomas. J Nucl Med. 1987 Dec;28(12):1807–1819. [PubMed] [Google Scholar]
  2. Dauplat J., Ferriere J. P., Gorbinet M., Legros M., Chollet P., Giraud B., Plagne R. Second-look laparotomy in managing epithelial ovarian carcinoma. Cancer. 1986 Apr 15;57(8):1627–1631. doi: 10.1002/1097-0142(19860415)57:8<1627::aid-cncr2820570831>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  3. Haisma H. J., Moseley K. R., Battaile A., Griffiths T. C., Knapp R. C. Distribution and pharmacokinetics of radiolabeled monoclonal antibody OC 125 after intravenous and intraperitoneal administration in gynecologic tumors. Am J Obstet Gynecol. 1988 Oct;159(4):843–848. doi: 10.1016/s0002-9378(88)80150-9. [DOI] [PubMed] [Google Scholar]
  4. Jäger W., Adam R., Wildt L., Lang N. Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer. Arch Gynecol Obstet. 1988;243(2):91–99. doi: 10.1007/BF00932974. [DOI] [PubMed] [Google Scholar]
  5. Kabawat S. E., Bast R. C., Jr, Bhan A. K., Welch W. R., Knapp R. C., Colvin R. B. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol. 1983;2(3):275–285. doi: 10.1097/00004347-198303000-00005. [DOI] [PubMed] [Google Scholar]
  6. Rubin S. C., Hoskins W. J., Hakes T. B., Markman M., Cain J. M., Lewis J. L., Jr Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors. Am J Obstet Gynecol. 1988 Nov;159(5):1094–1098. doi: 10.1016/0002-9378(88)90420-6. [DOI] [PubMed] [Google Scholar]
  7. Sonnendecker E. W. Is routine second-look laparotomy for ovarian cancer justified? Gynecol Oncol. 1988 Oct;31(2):249–255. doi: 10.1016/s0090-8258(88)80001-5. [DOI] [PubMed] [Google Scholar]
  8. Stuart G. C., Jeffries M., Stuart J. L., Anderson R. J. The changing role of "second-look" laparotomy in the management of epithelial carcinoma of the ovary. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 1):612–616. doi: 10.1016/s0002-9378(16)32428-0. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES